1. Clinical & Scientific Overview
Multiminerals (TIP-MED-000378, Reference Code [10.4]-C108) is classified under
Vitamins, Minerals & Nutritional Supplements (Ch 10) as a Comprehensive Micronutrient Supplement (Fat-Soluble Vitamins A, D, E, K + Water-Soluble Vitamins B, C + Trace Minerals Zn, Mg, Se, Cu, Cr, Mn).
Within the Indian regulatory and compendial framework, it is governed under Non-Schedule / OTC or Schedule K Permitted Preparation (Medical Supervision Recommended for High-Dose/Therapeutic Regimens).
Co-indexed constituent under primary monograph [10.4] (Multivitamins and Multiminerals). Representative Indian Market Examples (Edition 2.7 Ch 10 [10.4], p. 128): Supradyn (Bayer), Zincovit (Apex), Revital-H (Sun Pharma—contains Ginseng), A to Z NS (Alkem), Becadexamin (GSK), Maxirich — Strengths & Dosage Forms: Oral Film-Coated Tablets / Softgel Capsules & Syrups (Once-daily nutritional RDA / therapeutic formulations)
Oral Film-Coated Tablets / Softgel Capsules & Syrups (Once-daily nutritional RDA / therapeutic formulations)
3. Mechanism of Action & Pharmacodynamics
Comprehensive Micronutrient Supplement (Fat-Soluble Vitamins A, D, E, K + Water-Soluble Vitamins B, C + Trace Minerals Zn, Mg, Se, Cu, Cr, Mn) acting on target receptor/enzyme pathways in Vitamins, Minerals & Nutritional Supplements (Ch 10): clinical efficacy is mediated via Comprehensive Micronutrient Supplement (Fat-Soluble Vitamins A, D, E, K + Water-Soluble Vitamins B, C + Trace Minerals Zn, Mg, Se, Cu, Cr, Mn) for Micronutrient convalescence following acute infectious illness, surgery, burns, or trauma; documented dietary inadequacy, frailty, or anorexia in the elderly; malabsorption states..
4. Therapeutic Indications & Evidence-Supported Uses
- Micronutrient convalescence following acute infectious illness, surgery, burns, or trauma
- documented dietary inadequacy, frailty, or anorexia in the elderly
- malabsorption states
🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.
5. Educational Dosage Context, Formulations & Administration
Educational Dosing & Regimen Summary: General Adult Reference: 1 tablet or capsule once daily after a meal. Follow physician prescription.
Administration & Meal Timing: Take WITH or immediately AFTER breakfast or lunch (meals provide dietary fat for absorption of Vitamins A, D, E, and K, and prevent zinc/iron-induced empty-stomach nausea). | Once daily after breakfast or lunch (avoid bedtime if the brand contains Ginseng [e.g., Revital-H], which causes insomnia and blood pressure/heart rate elevation!).
6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment
Follows class pharmacokinetic profile detailed in parent monograph [10.4].
Renal: CRITICAL CKD WARNING: Standard over-the-counter multivitamins containing Vitamin A (Retinol), Potassium, or Magnesium MUST BE AVOIDED in advanced CKD (Stages 4–5 / Dialysis)! (The failing kidney cannot excrete retinol-binding protein, leading to Vitamin A toxicity, hypercalcaemia, and bone resorption!). Hepatic: Avoid high-dose Vitamin A and iron in chronic liver disease.
Renal: CRITICAL CKD WARNING: Standard over-the-counter multivitamins containing Vitamin A (Retinol), Potassium, or Magnesium MUST BE AVOIDED in advanced CKD (Stages 4–5 / Dialysis)! (The failing kidney cannot excrete retinol-binding protein, leading to Vitamin A toxicity, hypercalcaemia, and bone resorption!). Hepatic: Avoid high-dose Vitamin A and iron in chronic liver disease.
Renal: CRITICAL CKD WARNING: Standard over-the-counter multivitamins containing Vitamin A (Retinol), Potassium, or Magnesium MUST BE AVOIDED in advanced CKD (Stages 4–5 / Dialysis)! (The failing kidney cannot excrete retinol-binding protein, leading to Vitamin A toxicity, hypercalcaemia, and bone resorption!). Hepatic: Avoid high-dose Vitamin A and iron in chronic liver disease.
7. Contraindications, Precautions & High-Risk Warnings
- Contraindicated in hypervitaminosis A or D, hypercalcaemia, haemochromatosis/iron overload (if iron-containing), and Wilson's disease (if copper-containing). Pregnancy Teratogenicity Warning: High-dose Retinol (Vitamin A >10,000 IU/day) in general adult multivitamins is teratogenic in the first trimester—pregnant women must ONLY take dedicated prenatal supplements! Avoid Retinol (Vitamin A) containing multivitamins in Chronic Kidney Disease!
Key Clinical Precautions: Renal: CRITICAL CKD WARNING: Standard over-the-counter multivitamins containing Vitamin A (Retinol), Potassium, or Magnesium MUST BE AVOIDED in advanced CKD (Stages 4–5 / Dialysis)! (The failing kidney cannot excrete retinol-binding protein, leading to Vitamin A toxicity, hypercalcaemia, and bone resorption!). Hepatic: Avoid high-dose Vitamin A and iron in chronic liver disease.
8. Adverse Effects Profile
- Mild nausea (if taken on empty stomach due to zinc/copper/iron salts), bright yellow urine (riboflavin), dark stools (if iron-containing).
- Hypervitaminosis A (headache, hepatotoxicity, bone pain, teratogenicity with chronic excess), chelation failure of concurrent antibiotics/thyroxine, ginseng-induced hypertension/tachycardia/hypoglycaemia.
9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions
- Chelation Hazard from Divalent Minerals (Zinc, Iron, Magnesium, Calcium) inside Multivitamins: Multivitamin-multimineral tablets chelate Levothyroxine, Fluoroquinolones (ciprofloxacin, levofloxacin), Tetracyclines (doxycycline), and Bisphosphonates—never swallow a multivitamin with the morning thyroid tablet or with an antibiotic (space by ≥2–4 hours)! Vitamin K inside certain multivitamins can mildly antagonise Warfarin if started/stopped erratically
- Biotin interferes with TSH/troponin lab assays
10. Clinical Monitoring, Patient Counselling & Storage
Clinical & Laboratory Monitoring: Monitor clinical parameters per parent monograph [10.4].
Pharmacist Patient Counselling Points:
- Patient Counselling Checklist: Schedule multivitamin tablets after lunch (1:30–2:00 PM) so the zinc, magnesium, and iron minerals inside them are safely separated by ≥4 hours from early-morning Levothyroxine or morning antibiotics. Advise hypertensive, diabetic, and cardiac CGHS patients to avoid OTC ginseng-containing tonics without physician approval.
- Meal & Clock Timing Instruction: Take WITH or immediately AFTER breakfast or lunch (meals provide dietary fat for absorption of Vitamins A, D, E, and K, and prevent zinc/iron-induced empty-stomach nausea). (Once daily after breakfast or lunch (avoid bedtime if the brand contains Ginseng [e.g., Revital-H], which causes insomnia and blood pressure/heart rate elevation!).)
- Missed Dose Protocol: Skip the missed dose and resume the next day with a meal.
- Geriatric Dispensing Pearl: Under CGHS guidelines, routine tonic/antioxidant multivitamins are restricted unless specifically indicated. Perform a strip-by-strip audit to stop duplicate vitamin combinations in elderly patients.
Storage, Stability & Dispensing Safeguards: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Oral Film-Coated Tablets / Softgel Capsules & Syrups (Once-daily nutritional RDA / therapeutic formulations)
11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)
12. Authoritative References, Regulatory Sources & Editorial Disclaimer
Primary Compendial & Guideline Reference: Indian Pharmacopoeia (IP 2022) • NFI • CDSCO
Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)
Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: VERIFIED_EDUCATIONAL_CONTENT
Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.
13. Related Reference Monographs, Educational Guides & Visual Concept
💊 Related Pharmacological / Category Profiles
- [10.10]-C117 Magnesium Bisglycinate — Essential Intracellular Divalent Cation (Cofactor for >300 ATP-De
- [10.12]-C118 Benfotiamine (Vitamin B1) — Essential Pyrophosphate Coenzyme for Carbohydrate Decarboxylation
- [10.16]-C122 Vitamin E (Tocopheryl Acetate) — Fat-Soluble Retinoid Epithelial/Visual Vitamin & Lipid-Peroxidati
- [10.16]-CMP123 Oral Isotretinoin (13-cis-Retinoic Acid) IP — Fat-Soluble Retinoid Epithelial/Visual Vitamin & Lipid-Peroxidati